Umami Bioworks

Umami Bioworks

Private
SingaporeHealthcare & Life Scienceshttps://umamibioworks.com

Last Round

Strategic

Aug 30, 2023

Total Funding Raised

$2.4M

Company Overview

Umami Bioworks is a food technology company that produces cultivated seafood intended to offer a healthy and sustainable alternative to traditional seafood.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials, Quality Management, ML Platforms

Business Model

B2B2C

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

cultivated seafoodlab-grown seafoodfood tech enablercellular agricultureseafood technology platformmarine cell linesB2B food techcultivated fishcultivated crustaceansalternative seafoodsustainable seafoodtechnology licensingcultivated caviarcultivated pet foodmarine ingredientsAI for R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Umami Bioworks Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Umami Bioworks Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicAug 30, 2023
GrantJan 3, 2023
GrantNov 17, 2022
Pre SeedMar 2, 2022

Key People

Founding team and executive leadership

Mihir Pershad

Founder CEO

Founding Team

Umami Bioworks Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2025

    Launched Virtual Marine Cell, an AI-powered metabolic simulator for aquatic species.

  • Oct 7, 2025

    Launched a new supplement using proprietary AI platform.

Umami Bioworks Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Umami Bioworks Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Umami Bioworks's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range41
Year Founded2020
Last FundingAug 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.